Growth Metrics

ProQR Therapeutics N.V (PRQR) Non-Current Debt: 2021-2025

Historic Non-Current Debt for ProQR Therapeutics N.V (PRQR) over the last 3 years, with Sep 2025 value amounting to $5,611.

  • ProQR Therapeutics N.V's Non-Current Debt rose 213.29% to $5,611 in Q3 2025 from the same period last year, while for Sep 2025 it was $5,611, marking a year-over-year increase of 213.29%. This contributed to the annual value of $4.9 million for FY2024, which is 105361.70% up from last year.
  • According to the latest figures from Q3 2025, ProQR Therapeutics N.V's Non-Current Debt is $5,611, which was down 99.90% from $5.4 million recorded in Q2 2025.
  • In the past 5 years, ProQR Therapeutics N.V's Non-Current Debt ranged from a high of $45.0 million in Q4 2021 and a low of -$4.8 million during Q2 2024.
  • Over the past 3 years, ProQR Therapeutics N.V's median Non-Current Debt value was $3.1 million (recorded in 2023), while the average stood at $1.9 million.
  • As far as peak fluctuations go, ProQR Therapeutics N.V's Non-Current Debt plummeted by 222.74% in 2024, and later surged by 213.29% in 2025.
  • Quarterly analysis of 5 years shows ProQR Therapeutics N.V's Non-Current Debt stood at $45.0 million in 2021, then plummeted by 90.31% to $4.4 million in 2022, then grew by 5.98% to $4.6 million in 2023, then rose by 6.03% to $4.9 million in 2024, then skyrocketed by 213.29% to $5,611 in 2025.
  • Its Non-Current Debt stands at $5,611 for Q3 2025, versus $5.4 million for Q2 2025 and $4,897 for Q1 2025.